Amgen (AMGN)

Candlestick chart with volume — data via Yahoo Finance · For educational use only

Dividends

Options Chain

• TEVA's Prolia Biosimilar Gets FDA Nod, Xolair Filing Accepted

  Teva wins FDA approval for Prolia biosimilar Ponlimsi and secures Xolair biosimilar filing review by the FDA and EMA, strengthening its biosimilars push.

  Yahoo·Mar 31, 2026positive

• FDA Says Amgen’s Tavneos Linked to Liver Injuries, Deaths

  The FDA said it has identified 76 cases of drug-induced liver injuries with reasonable evidence of being causally linked to Tavneos.

  Yahoo·Mar 31, 2026positive

• FDA Warns Of Fatal Liver Risks Linked To Amgen Tavneos Use

  FDA flags liver injury risk tied to Amgen Tavneos, citing drug-induced liver injury and rare vanishing bile duct syndrome complications.

  Benzinga·Mar 31, 2026positive

• April Dogs Of The Dow: One To Buy

  April 2026 Dogs of the Dow update: Verizon is the only “dividend dogcatcher” stock. Read the full list here.

  SeekingAlpha·Mar 31, 2026positive

• FDA Adverse Event Monitoring System Q4 2025 Flags Multiple Potential New Drug Safety Signals, Including Hypersensitivity, Hypogammaglobulinemia, Colitis, Aplastic Anemia And Rhabdomyolysis Under Evaluation

  https://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/october-december-2025-new-safety-information-or-potential-signals-serious-risks-identified-fda

  Benzinga·Mar 31, 2026positive

Sentiment scored by an AI model on article tone. Not investment advice.